Advanced Enzyme Tech

Advanced Enzyme Technologies approved an open-market buyback of up to 1.394 million shares at no more than ₹500 each, for a maximum outlay of ₹69.7 crore. The maximum repurchase represented 1.24% of paid-up capital and excluded promoters, the promoter group and persons in control. The board also approved buying the remaining 4.28% of JC Biotech for ₹7.98 crore, making the subsidiary wholly owned, and up to ₹2 crore of funding for Advanced Nutrazyme. For the June quarter, consolidated revenue rose 2.1% year on year to ₹189.8 crore, while net profit fell 4.6% to ₹38.6 crore. Advanced Enzyme reported FY26 revenue of ₹745.8 crore and net profit of ₹173.6 crore; human nutrition accounted for about 63% of revenue.

Powered by Tijori

** Enzymes and probiotics maker Advanced Enzyme Technologies' shares ADEN.NS rises as much as 17.28%, their biggest intraday percentage surge in over four years to 419 rupees, an 18-month high

** Uptick after ADEN reports a 62.2% year-on-year jump in March quarter profit

** Revenue from operations rises 21.6% to 2.03 billion rupees

** Human nutrition segment, which contributes to about 63% of the total revenue, rises 24% in the March quarter, while the animal nutrition segment is up 19% Y/Y

**Trading volume is 5,005,409 shares as of 11:10 a.m. IST, more than 18x the 30-day average volumes, data compiled LSEG shows

** ADEN up 35% in 2026 so far, exchange data shows

(Reporting by Bharath Rajeswaran in Bengaluru)

(([email protected]; +91 9769003463;))

July 25 (Reuters) - Advanced Enzyme Technologies Ltd ADEN.NS:

• ADVANCED ENZYME TECHNOLOGIES LTD - JC BIOTECH APPROVES COLLABORATION WITH RAYWATT SOLAR POWER

Source text: ID:nBSE2n5hlH

Further company coverage: ADEN.NS

(([email protected];))

** Advanced Enzyme Technologies ADEN.NS falls 2.9% to 287.9 rupees

** Probiotics maker's Q4 consol net profit falls 6.5% Y/Y, hurt by an ~18% spike in expenses; rev up 6%

** More than 465,000 shares traded, ~4x the 30-day avg

** YTD, ADEN loses ~15%

(Reporting by Aleef Jahan in Bengaluru)

(([email protected]))

Dec 5 (Reuters) - Advanced Enzyme Technologies Ltd ADEN.NS:

• UNIT TO FORM OF A NEW CORPORATION IN CALIFORNIA, US

• VALUE OF ASSETS TO BE TRANSFERRED BY SEB TO STARYA LABS UPTO $500,000

Source text: ID:nBSEKTThX

Further company coverage: ADEN.NS

(([email protected];;))

** Shares of Advanced Enzyme Technologies ADEN.NS up 3.3%

** Stock set for third straight session of gains

** Enzymes and probiotics maker's Sept-qtr consol net profit jumps 31% YoY; revenue up nearly 14%

** Trading vol is 3.3X the 30-day daily moving average

** Stock now up ~17% so far this year

(Reporting by Manvi Pant in Bengaluru)

(([email protected]; +918447554364;))

March 31 (Reuters) - Advanced Enzyme Technologies Ltd ADEN.NS:

• UNIT APPROVED PURCHASE OF ENTIRE BUSINESS UNDERTAKING OF SHRI GANESH INDUSTRIAL ENZYMES

• ACQUISITION VIA SLUMP SALE ON A GOING CONCERN BASIS FOR UPTO 9 MILLION RUPEES

Source text for Eikon: ID:nBSE8mxSFX

Further company coverage: ADEN.NS

(([email protected];))